Pediatric Perfusion Market Analysis: Demand Insights and Growth Forecast 2024-2033

The Business Research Company recently released a comprehensive report on the Global Pediatric Perfusion Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

According to The Business Research Company's, The pediatric perfusion market size has grown strongly in recent years. It will grow from $2.52 billion in 2023 to $2.73 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to early pediatric cardiac surgery milestones, pioneering perfusion techniques, evolution of pediatric perfusion equipment, foundational research in pediatric cardiology, emergence of pediatric heart centers.

The pediatric perfusion market size is expected to see strong growth in the next few years. It will grow to $3.69 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to global expansion of pediatric cardiac services, advancements in neuroprotection, investments in pediatric cardiac care, customized perfusion solutions, rise in hybrid operating room usage. Major trends in the forecast period include research in pediatric cardiac care, continuous education and training, focus on neuroprotection, pediatric-specific equipment development, evolving cannulation techniques.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/pediatric-perfusion-global-market-report

Market Drivers and Trends:

The prevalence of cardiac congenital disorders is expected to propel the growth of the pediatric perfusion market going forward. Cardiac congenital disorders refer to defects that are present at birth and can have an impact on the development and functionality of a baby's heart that affects how blood travels from the heart to the body's other organs. Pediatric perfusion is extensively used during cardiac surgeries to repair or correct structural defects in the heart and these surgeries may involve procedures such as ventricular septal defect (VSD) repair, atrial septal defect (ASD) repair, tetralogy of Fallot (TOF) repair, coarctation of the aorta repair, and many others. For Instance, in February 2023, according to World Health Organization, a Switzerland-based specialized agency of the United Nations responsible for international public health, congenital diseases are thought to be the cause of 240 000 newborn deaths globally within 28 days of birth each year. Furthermore, according to the report published by the Center for Diseases Control (CDC), in January 2022, a congenital cardiac abnormality affects approximately 40,000 births in the United States each year, accounting for about 1% of the global population. Therefore, the prevalence of cardiac congenital disorders is driving the growth of pediatric perfusion.

Product innovations are a key trend gaining popularity in the pediatric perfusion market. Major market players are concentrating their efforts on creating newer technologies such as cardiopulmonary bypass (CPB), and cardiovascular perfusion, extracorporeal technological advancements such as miniaturized extracorporeal circulation (MECC) systems, pediatric cardiac surgery, advanced oxygenators, and closed-loop perfusion systems. For Instance, in March 2023, LivaNova, a UK-based manufacturer of medical devices, launched Essenz Heart-Lung Machine, in the US region with a 510(k) clearance from the U.S. Food and Drug Administration. LivaNova's patient monitor and the Essenz Heart-Lung Machine combine to form a perfusion system used during cardiopulmonary bypass surgeries. During an open-heart operation, a perfusion system serves as the patient's heart and lungs. Additionally, it is suitable for both adult and pediatric patients and is mast-mounted to reduce distractions and maintain the area clean. The cockpit gives a centralized perspective from which to control the device and monitor all perfusion and patient data and also interfaces with external operating room devices and hospital information systems.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=10717&type=smp

Major Key Players of the Market:

Medtronic plc; Terumo Cardiovascular Systems Corporation; LivaNova PLC; B. L. Lifesciences Pvt. Ltd.; Eurosets; GE HealthCare Technologies Inc.; Nonin Medical Inc.; Koninklijke Philips N.V.; Sorin Group; Medivators Inc.; Cardinal Health Inc; Fluigent; Getinge AB; Xvivo Perfusion AB; Masimo Corporation; Philips Healthcare; Edwards Lifesciences Corporation; Maquet Holding B.V. & Co. KG; Smiths Medical Inc.; Fresenius Kabi AG; Nipro Medical Corporation; Hemovent GmbH; Spectrum Medical Ltd.; Braile Biomédica; Leviticus Cardio Ltd.; Medos Medizintechnik AG; Beijing Medos Electronic Medical Equipment Co. Ltd.; Medline Industries Inc.; B. Braun Melsungen AG; Baxter International Inc.; ALung Technologies Inc.; Novalung GmbH; SynCardia Systems LLC; Xenios AG

Pediatric Perfusion Market 2024 Key Insights:

• The pediatric perfusion market will grow to $3.69 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%.
• Pediatric Perfusion Market Surges Amidst Rising Prevalence Of Cardiac Congenital Disorders
• Livanova Unveils Advanced Technologies With The Essenz Heart-Lung Machine, Elevating Cardiopulmonary Bypass Surgeries
• North America was the largest region in the pediatric perfusion market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=10717&type=smp

Contact Us:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.